Aceclidine-based Eye Drops Effective in Treating Presbyopia, reveals phase 3 trial Jacinthlyn Sylvia7 April 2024 7:15 PM ISTThe recent press release from a prominent biopharmaceutical company, LENZ Therapeutics, Inc. unveiled promising findings from its Phase 3 CLARITY...
Relief: 54 year old AIIMS doctor accused of raping colleague granted anticipatory bail Kajal Rajput19 Feb 2024 1:22 PM ISTA week after the accused doctor was summoned, an organisation working for women’s rights demanded his suspension and arrest.
D Y Patil Medical College Hospital and Research Centre Introduces Cutting-Edge E-resources, Skills Labs, revolutionizes learning experience for students Kajal Rajput19 Feb 2024 11:00 AM ISTPune: Dr DY Patil Medical College, Hospital and Research Centre, Pimpri, Pune, has taken a significant leap in advancing medical education with the...
WHO Adds R21/Matrix-M Malaria Vaccine to Prequalified List Jacinthlyn Sylvia24 Dec 2023 8:45 PM ISTMalaria inflicts a disproportionate burden on children in the African Region, taking up nearly half a million lives annually. Global statistics from...
Orthopedician Dr Vishal Beri takes charge Facility Director Fortis Mulund Kajal Rajput27 Oct 2023 2:35 PM ISTA seasoned healthcare professional, Dr Beri has over two decades of experience in healthcare. Dr Vishal Beri has held leadership positions with...
Amlitelimab shows promising results for Atopic Dermatitis Jacinthlyn Sylvia15 Oct 2023 8:00 PM ISTSanofi unveiled promising outcomes from its Phase 2b trial, STREAM-AD, during the European Academy of Dermatology and Venereology (EADV) 2023...
Asymptomatic malaria suppresses immune system and must be treated: Study Isra Zaman18 May 2022 7:15 PM ISTIt is commonly thought that asymptomatic malaria infections decrease the chances of severe disease. Rather, the disease suppresses the immune system...
High risk of serious blood clots until six months post covid-19 infection: BMJ Isra Zaman7 April 2022 10:30 PM ISTThere could be a high possibility of occurrence of deep vein thrombosis, pulmonary embolism, and bleeding event for up to 3 months, 6 months, and 2...
Berotralstat reduces overall disease burden in hereditary angioedema: Study Medical Dialogues Editorial Team8 March 2022 9:00 AM ISTUSA: In a new study conducted by Emel Aygoren-Pursun and team, it was found that berotralstat, regardless of baseline attack rate, is an effective...
Updated CPR guidance in accordance with new variants of Covid-19 amid evolving pandemic: AHA Medical Dialogues Editorial Team24 Feb 2022 9:00 AM ISTUSA: The American Heart Association's (AHA) recent update on cardiopulmonary resuscitation (CPR) for patients with suspected or confirmed...
Molnupiravir harms offset stated benefits of the drug, reiterates ICMR Lalhmangaihkimi14 Jan 2022 3:52 PM ISTNew Delhi: The Indian Council of Medical Research (ICMR) is taking another strong stand against the antiviral drug, Molnupiravir for the treatment of...
Prophylaxis fitusiran may improve QoL and decrease bleeding in hemophilia patients: ATLAS-INH trial MD Editorial Team20 Dec 2021 9:00 AM ISTDelhi: The effectiveness of fitusiran 80 mg monthly subcutaneous prophylaxis in persons with hemophilia A or B with inhibitors was proven in Phase 3...
